Lime Peel Oil–Incorporated Rosin-Based Antimicrobial In Situ Forming Gel
Open Access
Abstract
Localized intra-periodontal pocket drug delivery using an injectable in situ forming gel is an effective periodontitis treatment. The aqueous insoluble property of rosin is suitable for preparing a solvent exchange-induced in situ forming gel. This study aims to investigate the role of incorporating lime peel oil (LO) on the physicochemical properties of injectable in situ forming gels based on rosin loaded with 5% w/w doxycycline hyclate (DH) in dimethyl sulfoxide (DMSO) and N-methyl pyrrolidone (NMP). Their gel formation, viscosity, injectability, mechanical properties, wettability, drug release, and antimicrobial activities were evaluated. The presence of LO slowed gel formation due to the loose precipitate formation of gel with a high LO content. The viscosity and injectability were slightly increased with higher LO content for the DH-loaded rosin-based in situ forming gel. The addition of 10% LO lowered gel hardness with higher adhesion. LO incorporation promoted a higher drug release pattern than the no oil-added formulation over 10 days and the gel formation rate related to burst drug release. The drug release kinetics followed the non-Fickian diffusion mechanism for oil-added formulations. LO exhibited high antimicrobial activity against Porphyromonas gingivalis and Staphylococcus aureus. The DH-loaded rosin in situ forming gel with an addition of LO (0, 2.5, 5, and 10% w/w) inhibited all tested microorganisms. Adding 10% LO to rosin-based in situ forming gel improved the antimicrobial activities, especially for the P. gingivalis and S. aureus. As a result, the study demonstrates the possibility of using an LO amount of less than 10% loading into a rosin-based in situ forming gel for efficient periodontitis treatment.Keywords
Funding Information
- Thailand Science Research and Innovation (TSRI) (no grant number)
This publication has 63 references indexed in Scilit:
- Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilmJournal of Oral Microbiology, 2013
- In situ forming implants — an attractive formulation principle for parenteral depot formulationsJournal of Controlled Release, 2012
- Cosolvent Effects on the Drug Release and Depot Swelling in Injectable In situ Depot-Forming SystemsJournal of Pharmaceutical Sciences, 2012
- Does the oral cavity represent an important reservoir for MRSA in healthcare workers?Journal of Hospital Infection, 2010
- Injectability of biodegradable in situ forming microparticle systems (ISM)European Journal of Pharmaceutical Sciences, 2009
- Prevalence of "non-oral" pathogenic bacteria in subgingival biofilm of subjects with chronic periodontitisBrazilian Journal of Microbiology, 2006
- Rosin Nanoparticles as a Drug Delivery Carrier for the Controlled Release of HydrocortisoneBiotechnology Letters, 2005
- Effect of Co-Solvents on the Controlled Release of Calcitonin Polypeptide fromIn SituBiodegradable Polymer ImplantsDrug Delivery, 2005
- Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853Antimicrobial Agents and Chemotherapy, 1979
- Activity of Tetracycline, Doxycycline, and Minocycline Against Methicillin-Susceptible and -Resistant StaphylococciAntimicrobial Agents and Chemotherapy, 1974